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ABSTRACT 
Objective: The main objective of this study was to evaluate the influence of marketing-mix concepts on the purchasing engagements of community 
pharmacists with supply channels in low and middle-income settings. Secondly, to use an Impact scale to measure the dominant marketing-mix 
factors that influence procurement decision-making practices. 
Methods: A descriptive study that used self-administered questionnaires, distributed to community pharmacists from March to May 2021 in 
Southwestern, Nigeria. A mixed-method sampling technique was adopted. Ethical approval was given by the Ministry of health (HPRS/381/371). 
Study outcomes were compared against measures of the Impact scale. Descriptive and Inferential statistics were used to test the study hypotheses 
using SPSS-25. Significance was set at p<0.05  
Results: The response rate was 79.6% representing 398 community pharmacists. Age of community pharmacists had significant association with 
price-sensitivity (p<0.01). Community pharmacists with more employees tended to be price-sensitive (p=0.003). Promotion variable had the 
highest influence (Mean score=2.73, SD=0.43, Impact-level=moderate), followed by Price (Mean score=2.65, SD=0.34, Impact-level=moderate), 
Place (Mean score=2.61, SD=0.51, Impact-level=moderate), Perception (Mean score=2.48, SD=0.42, Impact-level=low), and the least impactful was 
Product (Mean score=2.46, SD=0.41, Impact level=low). The study revealed an overall low-to-moderate involvement (Mean score=2.59, SD=0.42) 
and influence of marketing-mix on the level of engagement of community pharmacists with supply channels. 
Conclusion: Findings suggest a shift of focus away from product-based considerations. Therefore, the study recommends a more balanced decision 
approach using an Impact rating scale. Improved focus on key priorities that can positively impact quality pharmaceutical care to the patient is advocated. 
Keywords: Pharmacy practice, Community pharmacists, Marketing-mix, Purchasing, Decision-making, Impact, low and middle-income countries, 
Outcome Research, Healthcare services, Nigeria 
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INTRODUCTION 
Globally, the mechanisms involved in managing drug supply 
channels are central to the seamless management of a community 
pharmacy practice. Community pharmacists (CPs) are entrusted 
with the task of ensuring the supply and dispensing of 
recommended medicines as required by the patient. This value chain 
is characterized by the interplay of relationships between the 
patient, community pharmacist, and suppliers. The ideals of 
pharmaceutical care demand that this chain should be properly and 
efficiently managed to guarantee the availability of safe, efficacious, 
and affordable medicines for the patient [1, 2]. There is limited 
literature about the role and influence of marketing-mix on the 
purchase decisions of community pharmacists in practice settings. In 
low and middle-income countries, the role of marketing concepts in 
community pharmacy practice is yet to be explored. At the core of 
the marketing process, there are four typical elements-Product, 
Price, Promotion, and Place, all geared towards meeting the needs of 
the customer [3-6]. Price refers to the cost component; it 
encompasses how much is paid for the procurement of medicines. It 
also includes the cost of transportation of inventory from the 
supplier to the pharmacy, credit management and control, price 
negotiations, cost of business, cost of the product itself. Price is 
largely dependent on the capacity of the Community pharmacist to 
procure medicines with the associated costs [7] The chaotic drug 
distribution system and foreign exchange challenges in low and 
middle-income countries coupled with a barely existent social 
welfare system, negatively result in the escalation of cost to the 
patient and high drug acquisition costs to the community pharmacist 
with an attendant negative impact on profit margins. The overall 
impact of pricing on the value chain is that it influences how much 
the product will cost the patient [8-10]. In general terms, Product in 
the context of pharmaceutical sales and marketing refers to the 
pharmaceutical medicine or non-medicinal entities and their 
associated attributes used for the treatment needs of the patient 
[11].  
Associated aspects of Product are; product range, category or 
therapeutic group (prescription, and non-prescription drugs), 
product information needs, management of product quality 
concerns. The specific attributes and characteristics of the Product 
variable are dependent on the medication needs of the patient and 
the requirement of the CPs in terms of inventory needs [12]. The 
variable Place refers to the channels, avenues, and medium through 
which pharmaceutical products are made available, accessible on 
time to the CP with the patient as the focal point. It typically refers to 
how the supply chain mechanism delivers the product from the 
marketer or manufacturer to the final consumer [13-15]. The key 
elements of the place include distribution channel, access concerns, 
the proximity of location, ease of transportation, and logistics 
management [7]. Promotion refers to the set of activities targeted at 
improving the level and volume of the transaction between the 
supplier and the CP. These activities include awareness campaigns, 
prescription-generation from pharmaceutical companies, 
contractual agreements, discount offers on products, volume-based, 
and value-based discounts [16] The fifth element included in this 
study is Perception of value, albeit the presence of the typical 4P’s of 
marketing, the researchers explored the context of Perception to 
refer to how CPs perceive the entirety of offering from the channels 
they procure from per time. Perception elements include satisfaction 
with service quality, process flow, utility value, ease of business 
transaction, and administration [5, 11]. Furthermore, for a 
community pharmacy practice to be competitive, it should be able to 
maximally utilize (effective blend) the various elements of the 
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marketing mix, to arrive at an effective procurement decision. In a 
developing country like Nigeria, CPs daily take such decisions mainly 
from three main supply channels; pharmaceutical manufacturers or 
their licensed distributors, local wholesalers, and mega distributors 
from open drug markets [9, 10, 17]. The relevance of this study is 
that it further improves CPs’ understanding of the procurement 
process within the frame of the influence of marketing-mix concepts. 
In other words, the uniqueness of this is that it highlights the 
influence of the marketing mix from the perspective of the CPs. 
To the best of our knowledge, the influence of marketing mix 
concepts on the purchasing engagements of community pharmacists 
with supply channels in Nigeria has not been studied or evaluated.  
The main objective of the study is to explore the impact of the 
marketing mix on supply channel engagement by community 
pharmacists in Nigeria. Secondly, to use an Impact rating scale to 
measure the dominant marketing-mix factors that influence 
procurement decision-making practices in low and middle-income 
settings. 
The hypotheses of the study as stated in the null are as follows; a) 
There is no impact of price, product, promotion, place, and 
Perception on community pharmacists (CPs) involvement with 
existing supply channels in Nigeria, and, b) There is no dominant 
marketing-mix variable of operational importance to the study of 
Community pharmacists’ engagement with supply channels 
MATERIALS AND METHODS 
Ethical approval 
Ethical approval with approval number HPRS/381/371 dated 10th 
May 2021 from the Department of Health Planning, Research and 
Statistics, Ministry of Health, Ogun State, Nigeria. Informed oral 
consent was obtained from respondents before the administration of 
the research instrument 
Study design 
A cross-sectional study which used a descriptive-analytical 
technique with literature-guided questionnaires administered to 
community pharmacists in selected cities in South West, Nigeria 
Study setting and area 
The study took place in Lagos, Ogun, and Oyo states. They are the 3 
most populous states in the South Western part of Nigeria, with a 
population of over 21 million people, according to the data from the 
National Bureau of Statistics [18, 19]. The study frame consisted of 
all community pharmacists in Lagos, Ogun, and Oyo states. They 
have a total of about 1,800 community pharmacists.  
Questionnaire design 
A structured questionnaire was developed based on a 
comprehensive literature review and from the opinions of experts in 
the field. The questionnaire is composed of two parts, namely. The 
first part consists of socio-demographic variables. The second part 
consists of 26-item Likert scale questions classified based on 
literature-guided information into Price, Promotion, Place, Product, 
and Perception sub-headings or categories. The 5-point Likert scale 
options ranged from 1 to 5 where strongly agree (5), agree (4), 
undecided (3), disagree (2), and strongly disagree (1). 
Eligibility criteria 
Community pharmacists and/or pharmacist managers with 
procurement roles were included in the study. The rationale for this 
is to ensure that only pharmacists with relevant experience on 
procurement issues are recruited.  
Exclusion criteria 
Non-pharmacists and non-pharmacist managers were not included 
in the study. Pharmacists with no supervisory or oversight 
responsibility or involvement with drug procurement were also 
excluded. 
Sample size  
Raosoft sample size calculator was used to obtain a computed 
sample of 317 from a population of 1,800 community pharmacists in 
Lagos, Ogun, and Oyo states. A 5% margin of error and 95% 
confidence for sample size determination [20]. However, a total of 
398 respondents were obtained for the study. 
Sampling technique and data collection 
A mixed sampling method was adopted for the administration of the 
questionnaires in the study. Firstly, judgmental sampling was used 
to select community pharmacists with procurement roles. 
Thereafter, the Random sampling method was used to obtain 
respondents. This was done to minimize researcher bias in 
judgmental sampling 
Internal validity of research instrument 
The internal validity of the instrument was 0.78 Cronbach alpha 
coefficient. Face validity was achieved by an expert group of 
community pharmacists and academics 
Item definition, classification, and processing 
As shown in table 1 below, the Likert scale questions were applied to 
26-item questions to elicit responses from respondents as to their 
level of involvement with supply channels. The 26-items were 
categorized into 5 groups (Price, Place, Promotion, Product, and 
Perception) using the attributes inherent in the marketing-mix 
characteristics. 
Measurements of response and impact scale/s 
The 5-point Likert scale ranged from 1 (strongly disagree) to 5 
(strongly agree). To compute the range of responses, the difference in 
the value of the maximum and minimum was calculated (5-1=4) to 
give the class width. Data range was obtained by dividing the class 
width by the number of responses (4/5=0.8). This provided the range 
of scores to measure impact level as shown in table 1 below [21-23]. 
 
Table 1: Measures of impact scale for the study 
Likert scale Response Threshold range Impact level 
1 strongly disagree 1.00-1.80 Very Low (VL) 
2 disagree 1.81-2.60 Low (L) 
3 neutral 2.61-3.40 Moderate (M) 
4 agree 3.41-4.20 High (H) 
5 strongly agree 4.21-5.00 Very High (VH) 
 
Development of mean scores 
The mean scores of responses to the Likert scale questions were 
computed from each respondent’s answers to questions relating to 
purchasing engagements with three main supply channels in 
Nigeria, namely. Pharmaceutical companies, local wholesaler 
channels, and Mega Distributors in open-drug market channels. The 
mean scores were used for analysis. Mean scores for marketing-mix 
variables were made from the mean of item variables representing 
each marketing variable. Hence, ‘Product’ variable was obtained 
from the mean of response to items 1 to 7; ‘Price’ from items 8 to 15; 
‘Place’ from items 16 and 17; ‘Promotion’ from items 18 to 21; and 
‘Perception’ from items 22 to 26. 
Data analysis 
Descriptive statistics such as mean, standard deviation, and median and 
inferential statistical measures such as the Chi-square test were used to 
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test the significance of the association between categorical variables. T-
test was used to test the statistical difference in means between groups. 
RESULTS 
Response rates and demographic statistics 
A total of 398 were valid out of 500 questionnaires randomly 
administered to purposively selected community pharmacists (CPs) 
in Lagos, Oyo, and Ogun states from March to May 2021. This 
represented a response rate of about 79.6%, which was found to be 
sufficient for further statistical use. Demographic characteristics of 
respondents showed that 55% (217) were male and 45% (181) 
female. 79% (314) have Bachelor of Pharmacy as first degree 
compared to 21% (84) who had Doctor of Pharmacy. 90% (359) 
have no postgraduate degree, compared to 10% (39) who had 
postgraduate qualifications. Age-wise, 76.7% (305) of respondents 
were between 20 to 40 y compared to 93 (23.3%) who were above 
41 y. The business model operated by CPs was 60% (238) core 
retail, 15% (59) wholesale, and 25% (101) operated mixed model. 
Type of owner showed that 54% (213) were sole owners, 16% (62) 
partnership, and 30% (123) were pharmacist-managers. Years of 
experience as a pharmacist showed 40% (158) within 1 to 5 y, 34% 
(136) between 6 to 10 y, while 26% (104) between 11 to above 20 y. 
Employee number count revealed the majority 57% (227) had 1 to 5 
persons, 30% (120) had 6 to 10 persons, while a cumulative 12.8% 
(51) had between 11 to over 20 employees. In terms of location, 
55% (218) respondents in Urban, 32% (127) in Suburban, and 13% 
(53) in rural respondents. 
 
Table 2: Test of association between demographic attributes of community pharmacists and marketing mix variables 
Variables  X2 Marketing marketing-mix variables  
Demographics p-value Price  Product Place  Promotion  Perception 
Age 0.05 **0.00 0.09 0.20 0.09 0.15 
Gender 0.05 0.72 0.24 0.60 0.30 0.15 
Type of Ownership 0.05 0.54 0.76 *0.03 0.62 0.15 
Years of Managerial experience 0.05 *0.01 0.38 0.61 0.25 0.70 
Years of experience as pharmacist 0.05 0.10 0.84 0.91 0.37 0.21 
Business model 0.05 0.67 0.08 0.07 0.11 0.07 
Location of Business premise 0.05 0.61 0.78 0.14 0.28 *0.05 
Number of employees 0.05 **0.00 0.38 *0.02 0.11 0.60 
State of Operation 0.05 0.07 0.74 0.18 0.34 0.11 
Note: p-value significant at<0.05, *p<0.05, **p<0.01, 95% Confidence Interval 
 
Table 3: Evaluation of variables involved in community pharmacists’ engagement with supply channels 
Study variables Mean SD Impact level Ranking t-value p-value Inference 
Product  2.46 0.41           
Items               
1. Product variety 2.41 0.64 low 5 1.312 0.189 not significant 
2. purchase mostly non-prescription drugs 2.5 0.71 low 3 0.973 0.331 not significant 
3. purchase mostly prescription-only drugs 2.45 0.67 low 4 1.016 0.31 not significant 
4. Provision for return/replacement of defective products 2.51 0.65 low 2 1.298 0.195 not significant 
5. Assured product quality and source 2.4 0.61 low 6 0.271 0.786 not significant 
6. purchase both non-prescription and prescription-only 
medicines 
2.3 0.66 low 7 2.824  **0.005  significant 
7. Product information from supplier 2.61 0.61 moderate 1 5.429  **0.000  significant 
PRICE 2.65 0.34           
Items               
8. Get better product pricing 2.38 0.58 low 8 8.012  **0.000  significant 
9. Spend less on transportation costs  2.52 0.58 low 5 3.858  **0.000  significant 
10. Negative impact on profit margins 3.18 0.85 moderate 1 11.55  **0.000  significant 
11. Opportunity to negotiate pricing  2.61 0.6 moderate 3 1.157 0.248 not significant 
12. Increased cost of doing business 2.94 0.7 moderate 2 7.434  **0.000  significant 
13. Regular Updates on price changes 2.52 0.6 low 6 3.761  **0.000  significant 
14. Access to credit facility  2.6 0.63 low 4 1.393 0.164 not significant 
15. More profit-making opportunity from the channel 2.44 0.6 low 7 6.075  **0.000  significant 
PLACE 2.61 0.51           
Items               
16. Ease of access to supplier 2.41 0.64 low 2 4.876  ** 0.000  significant 
17. Proximity to Business Premise 2.8 0.69 moderate 1 4.418  **0.000  significant 
PROMOTION 2.73 0.43           
Items               
18. Enjoy promos on volumes purchased 2.58 0.62 low 3 3.966  **0.000  significant 
19. Buy large volumes as a result of their activities 2.55 0.62 low 4 4.759  **0.000  significant 
20. Buy small quantities as a result of their activities 2.76 0.7 moderate 2 0.729 0.466 not significant 
21. Have Contractual Business agreements with the 
supplier 
3.03 0.9 moderate 1 6.000  **0.000  significant 
PERCEPTION 2.48 0.42      
Items               
22. Enjoy the seamless business flow 2.21 0.58 low 5 7.522  **0.000  significant 
23. Enable meeting Customers’ needs promptly 2.37 0.65 low 4 2.836  **0.005  significant 
24. Improves administrative time for other activities 2.55 0.62 low 2 1.865 0.063 not significant 
25. Enjoy satisfactory service from supplier 2.43 0.61 low 3 1.347 0.178 not significant 
26. Experienced improved Business activity due to COVID 
in the past year 
2.74 0.41 moderate 1 8.837  **0.000  significant 
 Note: p-value significant at<0.05, *p<0.05, **p<0.01, 95% Confidence Interval, SD=standard deviation 
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Table 2 showed that demographic variables of age, type of 
ownership, number of employees, years of managerial experience 
were significantly associated with marketing-mix variables such as 
Price (Age, number of employees, managerial experience), Place 
(type of ownership, number of employees), Perception (location of 
business premise). However, Product and Product did not show any 
significant association with any of the demographic attributes of 
Community pharmacists. The association of Age will price 
component had the highest significance (p<0.001) compared to the 
number of employees with Price (p=0.003). 
Table 3 shows various items in each marketing-mix category and 
their respective Impact ratings. It also reveals the t-values obtained 
from comparing the means of each Marketing variable with that of 
each item in each category. Under the category Product, all items had 
‘low impact scores’ below the threshold outlined in table 1. 
However, only the item "supply of product information" had a 
moderate impact level under the category. 
However, under the Price category, moderate impact scores were 
obtained from items 'negative impact on margins', 'opportunity to 
negotiate prices' and 'Increase the cost of doing business Similarly, 
under the Promotion category, items “buy small quantities as a result 
of promo activities’ and ‘have contractual business agreements with 
supplier’ both had moderate impact scores compared to other items. 
Perception category had only one moderate impact level item 
‘experienced improved business due to COVID in the past 12 mo. 
Table 4 provides a summary of the Marketing-mix variables and 
their mean score, impact level, and ranking. 'Promotion' had the 
highest-ranking with moderate impact, followed by Price with 
moderate impact, Place with moderate impact, Perception with low 
impact, and lastly, Product with low impact. 
  
Table 4: Impact of marketing-mix variables on community pharmacists’ engagement and hypothesis testing 
Marketing-mix variables Mean SD Impact level Ranking Inference {Hypothesis) 
Product 2.46 0.41 low 5 Low impact on CPs’ decision  
Price 2.65 0.34 moderate 2 Moderate impact on decision-making  
Place 2.61 0.51 moderate 3 Moderate impact on decision  
Promotion 2.73 0.43 moderate *1 Moderate impact on decision  
Perception 2.48 0.42 low 4 Low impact on CPs’ decision  
Overall value  2.59 0.42 low-moderate not applicable Reject null hypothesis 
SD=standard deviation, *Promotion is the most dominant marketing-mix variable 
 
DISCUSSION 
The uniqueness of this study is that it shifts the mirror of analysis 
from the perspective of suppliers to those at the retail end of the 
value chain, (the CPs), as to how they engage marketing-mix 
principles to inform their procurement decisions. There were 
several limitations to the study. Firstly, the study was carried out in 
the southwest region of Nigeria and hence, the generalizability of the 
result is therefore limited. The marketing-mix attributes in the 
questionnaire need to be expanded to include more factors to 
enhance study outcomes. The outcomes of the study based on tables 
3 and 4 were expounded as follows:  
The impact of the ‘product’ on CPs procurement engagement with 
Supply channels revealed that overall involvement was low. The 
findings showed that the mean scores of product items revealed very 
low involvement in terms of engagement with the least rank apart 
from item ‘product information obtained from suppliers’ with a 
moderate score. This is particularly of considerable concern due to 
the near absence of quality checks on products before procuring, 
inadequate focus on the reliability of sourcing, whether from 
pharmaceutical companies, wholesalers, and mega distributors. This 
is because the issue of fake and counterfeit medicines is an ongoing 
challenge in developing countries, including Nigeria [9, 17].  
The impact of ‘price’ on CPs procurement engagement with Supply 
channels showed that overall involvement was moderate. The study 
found out that profit-making from suppliers was least impactful 
compounded by high-cost transportation of goods from supplier to 
retailer, which may perhaps negatively influence returns on 
investment and product availability as a consequence [7, 15]. This is 
probably linked to the limited access to credit facilities from suppliers.  
The impact of ‘promotion’ on CPs procurement engagement with 
Supply channels showed that ‘Promotion’ had the most impact on 
CPs’ engagement; which is indicative of the general focus of 
respondents. Promotion in the context of this study refers to the 
activities of suppliers towards increasing the level of awareness and 
patronage of their products. Although respondents mostly procured 
in small quantities compared to large quantities, contractual 
business arrangements with suppliers as a strategy to improve 
business volume were moderately adopted [16, 20, 25]. 
Furthermore, the impact of ‘place’ on CPs procurement engagement 
with Supply channels revealed the overall impact of Place was 
‘moderate’. In addition, the study showed that community 
pharmacists considered proximity to the business premise with 
suppliers as critical to their engagement, as confirmed by moderate 
scoring of its involvement. However, the ease of access to the 
supplier was scored low. This represents a gap that should be 
managed because timeliness and ease of access to where medicines 
can be procured are important. This is in harmony with one of the 
tenets of rational drug use, which expects medicines to be available 
on time [13, 14]. However, proper inventory management at the 
community pharmacy level should be able to mitigate the likely 
negative effects of impaired access to suppliers. 
The study revealed that the impact of ‘perception’ on CPs 
procurement engagement with Supply channels had overall low 
involvement. In this study, perception is viewed from the 
perspective of the community pharmacist as per how CPs perceived 
overall value from suppliers and other related factors. Findings 
showed that business flow, ability to cater to patients' needs, 
administrative time savings, level of satisfaction with suppliers' 
services were all below expectation (low impact). This calls for more 
attention from supply chain managers involved in the supply of 
medicines to community pharmacies to proffer more efficient ways 
to ensure the availability of products and services to their clients. In 
contrast, respondents had a moderate level of response as to 
improved profitability in the last 12 mo. This spike in sales and 
profitability is not unrelated to an astronomical increase in the 
demand for medicines and healthcare products during the COVID-19 
lockdown period [24, 25]  
Finally, the overall impact of Marketing-mix variables on CPs 
procurement engagement with supply channels based on the 
findings of this study was evaluated [Table 4]. Aggregate impact 
was considered 'low-moderate'' as shown by a mean score of 
2.59 which is below 3.41 baseline for high impact. This implies 
that the level of involvement by CPs in activities and decisions 
involving MARKETING-MIX: product, price, promotion, place, 
and their perception of value has to be improved. This is very 
important in healthcare practice settings in low and middle-
income countries. The findings of this study showed that 
‘Promotion’ had the most significant impact on the engagement 
of CPs in the supply channel. This finding is supported by Thabit 
and Raewf, 2018 [26]. The study provided a framework to 
support balanced engagement between community pharmacists 
and their suppliers.  
T. E. Oamen & O. S. Omorenuwa 
Int J Pharm Pharm Sci, Vol 13, Issue 10, 20-24 
24 
The study hypotheses were therefore tested based on the outcomes 
of the study, the null hypothesis that there is no impact of marketing 
mix on CPs; engagement with supply channels was rejected because 
there was the low-moderate impact of marketing mix variables in 
CPs engagement. Also, the null hypothesis that there is no 
dominating marketing mix variable was rejected as the Product 
variable was the most dominant. This finding is supported by a study 
that examined the place of generic products in delivering affordable 
healthcare in developing countries [27]. 
Based on the study outcomes, there are implications for community 
pharmacy practice in low and middle-income countries where 
access to safe and affordable medicines is an essential indicator of 
qualitative healthcare delivery. It is essential for CPs to adopt a 
balanced blend of marketing-mix practices to ensure quality, price-
friendly, accessible, and service-driven pharmaceutical care delivery. 
In addition, the Implications for policymakers is that it is imperative 
to adopt and adapt Marketing-mix concepts (Product, Price, Place, 
Promotion, and Perception) towards optimizing the relationship 
between healthcare providers and supply channels of medicines. 
Healthcare providers can improve the quality of procurement 
decisions with the optimal application of marketing-mix concepts. 
The study provides a framework to support balanced engagement 
between community pharmacists and their suppliers. Improved 
focus on key priorities that can positively impact the delivery of 
pharmaceutical care to the patient. 
CONCLUSION 
The role of the marketing mix in healthcare cannot be 
overemphasized. Community pharmacists as frontline medication 
experts need to apply the principles of price, place, product, product, 
and perception, in informing their procurement activities. There is 
an apparent shift of priority focus from product-based attributes, to 
more of price-sensitivity, stock availability and access. The study 
recommends a more balanced approach to be adopted among 
healthcare managers when making procurement decisions. 
LIMITATIONS OF THE STUDY 
There are several limitations of the study, firstly, the research study 
was conducted in the Southwestern part of Nigeria and hence there 
is the limitation of generalizability to other geographical regions of 
the country. Secondly, there is the need to expand/increase the 
number of attributes constituting each marketing mix concept. 
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